Funding of US Biomedical Research, 2003-2008
Funding of US Biomedical Research, 2003-2008
复制标题
DOI:
10.1001/jama.2009.1987
复制
发表时间:
2010-01-13
影响因子:
120.7
通讯作者:
Moses, Hamilton, III
中科院分区:
文献类型:
--
作者:
Dorsey, E. Ray;de Roulet, Jason;Moses, Hamilton, III
Context With the exception of the American Recovery and Reinvestment Act, funding support for biomedical research in the United States has slowed after a decade of doubling. However, the extent and scope of slowing are largely unknown.Objective To quantify funding of biomedical research in the United States from 2003 to 2008.Design Publicly available data were used to quantify funding from government (federal, state, and local), private, and industry sources. Regression models were used to compare financial trends between 1994-2003 and 2003-2007. The numbers of new drug and device approvals by the US Food and Drug Administration over the same period were also evaluated.Main Outcome Measures Funding and growth rates by source; numbers of US Food and Drug Administration approvals.Results Biomedical research funding increased from $75.5 billion in 2003 to $101.1 billion in 2007. In 2008, funding from the National Institutes of Health and industry totaled $88.8 billion. In 2007, funding from these sources, adjusted for inflation, was $90.2 billion. Adjusted for inflation, funding from 2003 to 2007 increased by 14%, for a compound annual growth rate of 3.4%. By comparison, funding from 1994 to 2003 increased at an annual rate of 7.8% (P